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The  process  of  adipogenesis  is controlled  in  a highly  orchestrated  manner,  including  transcriptional  and
post-transcriptional  events.  In developing  3T3-L1  pre-adipocytes,  this  program  can  be interrupted  by
all-trans retinoic  acid  (ATRA).  To  examine  this  inhibiting  impact  by ATRA,  we  generated  large-scale  tran-
scriptomic  data  on  the  microRNA  and  mRNA  level.  Non-coding  RNAs  such  as  microRNAs  represent  a ﬁeld
in RNA  turnover,  which  is very  important  for understanding  the  regulation  of  mRNA  gene  expression.
High  throughput  mRNA  and  microRNA  expression  proﬁling  was  performed  using mRNA  hybridisation
microarray  technology  and  multiplexed  expression  assay  for microRNA  quantiﬁcation.  After  quantitative
measurements  we  merged  expression  data  sets,  integrated  the  results  and analysed  the  molecular  regu-
lation  of  in  vitro  adipogenesis.  For  this  purpose,  we  applied  local  enrichment  analysis  on  the  integrative
microRNA-mRNA  network  determined  by a  linear  regression  approach.  This approach  includes  the  target
predictions  of  TargetScan  Mouse  5.2 and  23 pre-selected,  signiﬁcantly  regulated  microRNAs  as  well  as
Affymetrix  microarray  mRNA  data. We  found  that  the  cellular  lipid  metabolism  is  negatively  affected
by  ATRA.  Furthermore,  we  were  able  to show  that  microRNA  27a  and/or  microRNA  96 are  important
regulators  of gap  junction  signalling,  the  rearrangement  of the actin  cytoskeleton  as  well  as  the  citric
acid  cycle,  which  represent  the  most  affected  pathways  with  regard  to  inhibitory  effects  of  ATRA in 3T3-
L1 preadipocytes.  In  conclusion,  the  experimental  workﬂow  and  the  integrative  microRNA–mRNA  data
analysis  shown  in  this  study  represent  a possibility  for illustrating  interactions  in highly  orchestrated
biological  processes.  Further  the applied  global  microRNA–mRNA  interaction  network  may  also  be  used
for the  pre-selection  of potential  new  biomarkers  with  regard  to obesity  or  for  the  identiﬁcation  of  new
pharmaceutical  targets.
©  2016  The  Author(s).  Published  by  Elsevier  GmbH.  This  is  an open  access  article  under  the  CC  BY. IntroductionPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
Dietary behaviour has a strong inﬂuence on body energy
etabolism. White adipose tissue (WAT) is the major storage depot
or excess energy and is involved in energy homeostasis. WAT  is
∗ Corresponding author at: Animal Physiology and Immunology, School of Life
ciences Weihenstephan, Technical University of Munich, Weihenstephaner Berg 3,
reising 85354, Germany.
E-mail address: michael.pfafﬂ@wzw.tum.de (M.W.  Pfafﬂ).
ttp://dx.doi.org/10.1016/j.bdq.2016.11.001
214-7535/© 2016 The Author(s). Published by Elsevier GmbH. This is an open access artlicense  (http://creativecommons.org/licenses/by/4.0/).
mainly composed of mature adipocytes and pre-adipocytes as well
as other cell types. An expansion of adipose tissue is usually because
of an increase in fat cell volume, but in the case of severe forms of
obesity, it is also characterised by fat cell hyperplasia caused by
preadipocyte differentiation. This process is regulated in a highly
complex manner and includes many regulatory components [1].
However, the enlargement of body fat mass and an increase in bodydifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
mass index (BMI) depends on a chronic positive energy balance [2].
Adipogenesis, the process of fat cell differentiation can be
affected by various endogenous and/or exogenous factors. Accord-
ingly, nutrients or other compounds affecting adipogenesis exert
icle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ifferent modes of action by inﬂuencing factors such as adipocyte
ize and number, and the secretion of hormones regulating hunger,
atiety or energy expenditure [3]. Fructose, nicotine, pesticides,
ndustrial chemicals or pharmaceuticals like estradiol are able
o mediate pro-adipogenic functions in mammals and are called
besogenic compounds [3,4]. On the other hand, anti-adipogenic
ompounds also exist in nature. All-trans retinoic acid (ATRA), a
itamin A derivate, is capable of modulating differentiation [5–7].
hereby, the differentiation of osteoblasts [8] and myoblasts [9]
s induced, whereas the development of adipocytes is inhibited
10–12]. The effects of ATRA strongly depend on its concentra-
ion, duration of action and target cell type [13]. Retinol and
arotenoids, the precursors of retinoic acid, are found in many
oods, e.g. meat, milk and vegetables, and in high concentrations
n carrots. After absorption from the diet, retinoic acid is trans-
orted to various tissues including, WAT, and is metabolised inside
he cells [5,7]. The effects of ATRA on adipogenesis have be exam-
ned in cell culture models e.g. the mouse 3T3-L1 pre-adipocyte
ell line [14]. In conﬂuent growth-arrested 3T3-L1 pre-adipocytes,
n adipogenic stimulus initiates a limited clonal expansion before
he cells enter the phase of terminal differentiation, including
ipid accumulation [15–17]. For this, the sequential induction of
he transcription factors Cebp˛, Cebp  ˇ [18] and Ppar [19–21] is
ecessary. Thereafter, adipocyte speciﬁc genes and enzymes are
nduced [22], and cell morphology is changed by reorganisation
f the cytoskeleton from a ﬁbroblast-like appearance towards a
pherical shape [22,23]. Recent data suggest that the develop-
ent of mature adipocytes is initiated by transcriptional as well as
ost-transcriptional changes conveyed by small non-coding RNAs.
icroRNAs (miRs) are small non-coding RNA species, and regula-
ion takes place through both, mRNA degradation or suppression
f translation [24,25]. This mechanism was initially discovered in
lants and Caenorhabditis elegans by Lee et al. and was reported to
e associated with the regulation of gene expression and cell differ-
ntiation and with guarding organisms against external nucleotide
equences such as viruses, transposons or parasites [26].
The present study aimed to further study the molecular mech-
nisms induced by ATRA in 3T3-L1 mouse preadipocytes at the
ranscriptome and phenotypic levels in a high-resolution time
rame. Therefore, we used the method of oil-red-O staining for
henotyping and microarray technology, reverse-transcription
uantitative polymerase chain reaction (RT-qPCR) and a multi-
lexed assay for expression proﬁling at both the mRNA and miR
evels. Pre-adipocytes were treated with ATRA in a time frame from
 h to 288 h (12 days) post-treatment. In addition, to generate a
omprehensive picture of regulatory networks of the physiologi-
al processes, we combined these high-throughput transcriptional
ata sets to create a two-level regulatory mRNA-miR network of
ranscriptomic data.
. Materials and methods
.1. Cell culture for maintenance
For all experiments, the mouse preadipocyte cell line 3T3-
1 (ATCC®/LGC Standards GmbH, Wesel, Germany) was used,
nd cells were cultured as described by the supplier. The cells
ere maintained in T175 ﬂasks (Nalgene Nunc International/Fisher
cientiﬁc, Schwerte, Germany) with ﬁbroblast medium consist-
ng of 500 ml  Dulbecco’s modiﬁed Eagleı´s medium (DMEM) (LGC
tandards GmbH, Wesel, Germany), 10% new born calf serumPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
PAN Biotech GmbH, Aidenbach, Germany) and 1% penicillin-
treptomycin (InvitrogenTM, Darmstadt, Germany). Cells were
ubcultured every 3 days. Following this, the cells were washed
ith phosphate-buffered saline (PBS) (PAA Laboratories GmbH, PRESS
d Quantiﬁcation xxx (2016) xxx–xxx
Cölbe, Germany), and the cell layer was  detached with 0.25%
Trypsin–EDTA (Life Technologies GmbH, Darmstadt, Germany). Cell
culture was performed at 37 ◦C in a humidiﬁed 5% CO2 incubator.
2.2. Experimental cell culture
Initially, cells were resuspended in ﬁbroblast medium and
1.8 × 105 cells were seeded per six wells (Nalgene Nunc Interna-
tional/Fisher Scientiﬁc, Schwerte, Germany). After 5 days, when
pre-conﬂuence was reached, the ﬁbroblast medium was renewed
and the cells were cultured for another 2 days. The ﬁbroblast
medium was  replaced by differentiation medium (DMI), con-
taining 10% foetal bovine serum (FBS) (PAN Biotech GmbH,
Aidenbach, Germany), 1% penicillin–streptomycin, 0.5 mM 3-
Isobutyl-1-methylxanthin (IBMX) (Sigma Aldrich, Taufkirchen,
Germany), 1 M dexamethasone (DEX) (Sigma Aldrich) and
1 g/ml insulin (Sigma Aldrich) in 500 ml  DMEM.  The 3T3-L1
preadipocytes were cultivated with DMI  in the presence and
absence of 3 M ATRA (Sigma Aldrich, Taufkirchen, Germany). After
96 h, DMI  was  replaced by growth medium (±3 M ATRA) con-
taining 10% FBS, 1% penicillin–streptomycin and 1 g/ml insulin
in 500 ml  DMEM.  The medium was renewed every 2 days. ATRA-
treated and −untreated 3T3-L1 cells were harvested after 0, 2, 4, 7,
10, 24, 48 and 96 h and again after 288 h (12 days).
2.3. Evaluation of RNA quality
Cellular RNA of ATRA-treated and untreated 3T3-L1
preadipocytes was extracted using the RNeasy Kit (Qiagen,
Hilden, Germany), as described by the supplier. RNA was eluted
in RNase-free water. The RNA concentration and purity were
determined using the Spectrophotometer NanoDrop1000 (Nano-
Drop products, Wilmington, USA) and Bioanalyzer 2100 (Agilent
Technologies, Mannheim, Germany).
2.4. cDNA synthesis
For gene expression proﬁling, 500 ng of total RNA per sample
was reverse transcribed into ﬁrst-strand cDNA. For cDNA synthesis,
the Moloney murine leukaemia virus reverse transcriptase H- (M-
MLV  RT H-) (Promega, Mannheim, Germany), 10 mM  dNTPs and
50 M hexamer primers were utilised in a total volume of 31 l.
The reaction mix  was incubated for 20 min  at 21 ◦C, following which
the cDNA synthesis step was performed for 120 min  at 48 ◦C. The
reaction was stopped by 2-min incubation at 90 ◦C.
For the reverse transcription of mature miRs, we used the miS-
cript RT Kit (Qiagen), as described by the supplier. The total volume
of each reaction was  20 l. We  used 300 ng total RNA. The RT reac-
tions were performed by incubation for 1 h at 37 ◦C, and the cDNA
reaction was stopped by incubation at 95 ◦C for 5 min. Thereafter,
cDNA was  diluted 1:4 with RNase-free water and stored at −20 ◦C.
2.5. RT-qPCR for mRNA quantiﬁcation
RT-qPCR was performed using a CFX384 Touch real-time
detection cycler (Bio-Rad Laboratories, Munich, Germany), and
the SsoFast EvaGreen Supermix (Bio-Rad Laboratories) was  used
for gene expression proﬁling. Gene primers (200 nM)  and 1 l
of ﬁrst-strand cDNA were added to the master mix. From
the entire set of all quantiﬁed genes the most stable mRNAs
were selected for data normalisation. We  applied the geomet-differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
rical average of the following four stably expressed reference
genes: Glyceraldehyde-3-phosphate dehydrogenase (Gapdh); Non-
POU-domain-containing Octamer-binding protein (Nono); Beta
Actin (Actb) [27]; and Importin 8 (Ipo8). We quantiﬁed the
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xpression of following genes of interest: Peroxisome proliferator-
ctivated receptor gamma  (Ppar); CCAAT/enhancer-binding
rotein (C/EBP), alpha (Cebp˛); CCAAT/enhancer-binding protein
C/EBP), beta (Cebpˇ); sterol regulatory element binding transcrip-
ion factor 1 (Srebf1) and retinoid X receptor and alpha (Rxr˛).
ll primers were synthesized by Integrated DNA Technologies
Leuven, Belgium) and primer sequences are summarised in the
upporting information Table S1.
The following cycling conditions were used in CFX384 Touch
eal-time Detection Cycler (Bio-Rad): after initial activation for 30 s
t 98 ◦C, the cycle steps of denaturation for 5 s at 95 ◦C and anneal-
ng/elongation for 20 s at 60 ◦C were repeated for 39 cycles. Melting
urve analysis was applied to conﬁrm the integrity of generated RT-
PCR products by a single amplicon peak. The melting curve was
enerated from 65 ◦C to 95 ◦C with an increment of 5 ◦C/5 min.
.6. RT-qPCR for miR  quantiﬁcation
For miR  expression proﬁling, we used the miScript SYBR Green
CR Kit (Qiagen, Hilden, Germany), as described by the supplier.
he total volume of each reaction was 10 l, including 1 l tem-
late cDNA, 1 l 10 × miScript Universal Primer as well as 1 l of
he speciﬁc 10 × miScript Primer Assay. The following conditions
ere used: initial activation 15 min  at 95 ◦C, denaturation 15 s at
4 ◦C, annealing 30 s at 55 ◦C and extension 30 s at 70 ◦C. After data
ollection at the extension step, melting curve analysis was per-
ormed in the same manner as that mentioned for gene expression
roﬁling. For normalisation, we calculated the geometrical average
f all measured miRs, including miR-26b, miR-29a-5p, miR-29b-5p,
iR-93, miR-96, miR-103, miR–miR-146, miR-221 and miR-365, as
ell as the miScript PCR Controls RNU5a, RNU6b, RNU1a, SNORD25
nd SNORA73a [28]. Quantiﬁed miR  sequences are listed in the
upporting information Table S2.
.7. Expression data normalisation
All internal reference genes at the mRNA and miR  level were
valuated with geNorm [29] and NormFinder [30] both part of
he gene expression analysis software suite GenEx 5.4.2 (Mul-
iD, Gothenburg, Sweden). All relative expression changes are
epresented as fold changes according to the following formula:
C = 2−Ct [31].
.8. MIQE compliance
Quantitative PCR assays were validated according to the MIQE
uidelines [32] (for details see the MIQE checklist in the appendix).
n brief; sample and RNA integrity were evaluated; exon span-
ing primer design was done using Primer 3 web version; PCR
ssay efﬁciency (96.2 ± 5.6%) was evaluated using dilution series;
elative gene expression data were analysed with MIQE approved
lgorithms using GenEx 5.4.2 software package.
.9. Microarray mRNA gene expression proﬁling
Using the GeneChip® Mouse Gene 1.0 ST Array (Affymetrix,
anta Clara, United States), 28,853 well annotated genes are
etectable. Using the Gene Chip Array, the gene expression pro-
les in the presence and absence of 3 M ATRA were analysed in
T3-L1 cells at eight different time points (0, 2, 4, 7, 10, 24, 48
nd 96 h). Therefore, three independent cell culture experimentsPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
ere conducted, and RNA was extracted as mentioned above. In
otal, 100 ng total RNA of each sample was used as the starting
aterial for microarray hybridisation [33]. An Affymetrix process-
ng protocol was utilised [34], and 45 arrays were performed by PRESS
d Quantiﬁcation xxx (2016) xxx–xxx 3
the Genomic Core Facility of the European Molecular Biology Lab-
oratory (EMBL, Heidelberg, Germany). For data normalisation, the
GeneSpring GX Software (Agilent Technologies, Santa Clara, United
States) [35] was used and the robust multichip analysis (RMA)
algorithm was  applied. The data were analysed with regard to the
quality and quantity of the data. The microarray data were ver-
iﬁed by RT-qPCR, and the Pearson correlation coefﬁcients were
calculated. Data were analysed with the Multiexperiment Viewer
(Dana-Faber-Cancer-Institute, Boston, USA) [36]. Data were gener-
ated as well as analysed following the MIAME  guidance [37].
2.10. MiR expression analysis
For miR  expression proﬁling, the nCounter Mouse miR Expres-
sion Assay (NanoString, Seattle, United States) was  used [38,39].
Using this analysis system, 600 murine and murine-associated viral
miRs are detectable. A digital colour-coded barcode technology was
utilised, and each barcode was  attached to a single target-speciﬁc
probe corresponding to miR  of interest. MiR-speciﬁc probes were
designed against the annotations in mirBase version 18 [40,41].
These target-speciﬁc probes were mixed together with controls;
therefore, a multiplexed code set was  formed [38,39]. The miR
expression in the presence and absence of 3 M ATRA was  ana-
lysed in two independent cell culture experiments at nine different
time points (0, 2, 4, 7, 10, 24, 48 and 96 h and 288 h = 12 days). As
a starting amount for the assays, 100 ng total RNA was analysed
per sample. Each assay was  normalised on the basis of the geo-
metric mean of the top 100 expressed miRs, and a normalisation
factor relative to the mean of all samples was calculated for each
assay using the nSolver Analysis Software (NanoString Technolo-
gies). The normalisation factors for all assays ranged between 0.1
and 10; this range is also recommended by NanoString Technology
itself. Heatmaps were generated using the Multiexperiment Viewer
software [36].
2.11. Genomatix pathway system analysis (GePS)
For analysis of enriched biological processes (GO terms) in DMI-
treated and DMI  + 3 M ATRA-treated cells, we utilised the GePS
Software (Genomatix, Munich, Germany). Based on information
from public and proprietary databases as well as co-citations in
the literature, this software enables a comprehensive analysis of
enriched GO terms [42].
2.12. Gene ontology analysis
The GO terms determined by GePS were analysed by the open
source software REVIGO (Laboratory for information systems at
the Rudjer Boskovic Institute, Zagreb, Croatia) [43]. REVIGO sum-
marises lists of GO terms by excluding redundant terms using
a clustering algorithm. Only non-redundant terms are visualised
in clusters (rectangles). Related GO terms were summarised in
superclusters with the same colour code. We  selected the 50 most
enriched GO terms among the ATRA regulated genes over time
(0–96 h).
2.13. Building miR–mRNA regulatory networks
For building up an miR–mRNA regulatory network, we initially
set up a prediction-based network by combining the conserved tar-
get predictions of TargetScan [44]. We  then ﬁtted a generaliseddifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
linear model (GLM) on the scaled expression proﬁles of mRNA
and its predicted miRs for each gene and computed the regu-
larisation path for the elastic net penalty, which is implemented
in the GLMnet package for R [45]. Using 10-fold cross-validation,
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e could select only those miRNAs that explain the correspond-
ng mRNA regulation. Because we were primarily interested in
nti-correlative effects of miR–mRNA interaction, we  introduced
 negativity constraint by modifying the implementation in the
LMnet package [45]. The weight of the miR–mRNA relation cor-
esponds to the absolute coefﬁcient of the respective miR  in the
LM.
To identify pathways that are speciﬁcally affected by the net-
ork structure of the resulting miR–mRNA network, we  ﬁrst
alculated a p-value of pathway over-representation for each gene
n the network. From this, we deﬁned a set of neighbour genes for
ach gene. This set includes all genes that are targeted by the same
iRs as the gene itself. We  then applied Fisher’s exact test to test
or over-representation of the pathway gene set among the neigh-
our gene set of each gene. We  obtained a distribution of p-values
or every pathway. This was done for all pathways derived from the
yoto Encyclopedia of Genes and Genomes (KEGG) [46]. Following
his, we randomly permuted the labels 100 times and tested each
ime whether the p-value distribution of the original network was
igniﬁcantly shifted to lower p-values compared with the respec-
ive random network using a two-sample Kolmogorov–Smirnov
est. The visualisation of the pathways and the node colour-
ng according to the pathway over-representation was performed
sing Cytoscape 2.8.3 (Cytoscape Consortium, San Diego, USA) [47].
.14. Oil-red-O-staining
Lipid accumulation in ATRA-treated and −untreated 3T3-L1
ells was detected by oil-red-O staining [48]. On day 12 (288 h)
fter starting differentiation, the medium was discarded and the
ells were air dried for 20 min  and ﬁxed at room temperature by
dding 10% formalin in PBS for 15 min. After ﬁxation, the cells were
ir dried again and stained with a ﬁltered oil-red-O working solu-
ion for 1 h on the orbital shaker. For the working solution, the 0.5%
il-red-O isopropanol stock solution was diluted 3:2 with water.
tained cells were washed three times with distilled water, the
ells were air dried and the residual colour on the well sides was
emoved with an isopropanol-soaked cotton stick. The six-well-
lates were scanned and stored at 4 ◦C until dye extraction. The
ye was extracted from cells by adding 1 ml  of the dye extraction
olution. The cells were incubated with the solution for 1 h on the
rbital shaker, and the absorption was measured at 492 nm with a
late reader (Tecan Deutschland GmbH, Crailsheim, Germany).
. Results
.1. ATRA inhibits adipogenesis in a time-dependent manner
The well-known characteristic time-dependent phenotype
hanges were detected during differentiation of 3T3-L1 cells, as
ssessed by oil-red-O staining (Fig. 1a). The cells were cultured in
riplicates for 24, 48 and 96 h in DMI  medium (±3 M ATRA), and
MI medium was changed to growth medium (±3 M ATRA) after
he indicated times. All cultured cells were stained after 12 days
288 h) of differentiation. The growth medium was renewed every
 days. Cultures exposed only for the ﬁrst 24 h to 3 M ATRA
howed no signiﬁcant inhibition of differentiation. Lipid accumu-
ation was similar to control cultures that were exposed for 24 h to
MI only. The exposure to 3 M ATRA for 48 h resulted in the sup-
ression of lipid accumulation by 40%. Incubation of the cells with
TRA for more than 96 h caused further inhibition of lipid accumu-Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
ation. Therefore, incubation of 3T3-L1 preadipocytes with 3 M
TRA for 288 h (12 days) was highly efﬁcient; lipid droplets were
nly accumulated in a few cells. The capability for differentiation
n cells treated with ATRA for a long term (ATRA treatment persists PRESS
d Quantiﬁcation xxx (2016) xxx–xxx
from 0 h to 288 h) was similar to the phenotype of undifferenti-
ated cells, which were cultivated after growth arrest for a further
288 h (12 days) with ﬁbroblast medium (Fig. 1a). The morphology of
control and ATRA-treated cells was also visualised microscopically
as shown in Fig. 1b. In ATRA-treated cultures, only a few mature
adipocytes were detectable, whereas the control cultures were fully
differentiated.
3.2. High-throughput gene expression proﬁling in ATRA-treated
and -untreated cells
Using microarray technology, gene expression in DMI-treated
and DMI  + 3 M ATRA-treated 3T3-L1 cells was analysed during
the ﬁrst 96 h. The squared correlation coefﬁcients for all corre-
sponding triplicates were calculated (r2 > 0.95). Only transcripts
with signiﬁcant Affymetrix signal values (>30) and with a twofold
up- or down-regulation at a minimum of one time point were
included in the analysis. Fig. 1c depicts an overview of the rela-
tive gene expression trend, either up- or down-regulated, in the
control and ATRA-treated cells. After 2 h, 388 transcripts were
signiﬁcantly differentially expressed in 3T3-L1 preadipocytes. Of
these, 298 transcripts (77%) were up-regulated by DMI  and 62
transcripts (16%) were down-regulated by DMI, whereas only 21
transcripts (5%) were induced by 3 M ATRA and only seven
transcripts (2%) were repressed by 3 M ATRA. After 96 h, 1314
transcripts were signiﬁcantly regulated in 3T3-L1 preadipocytes.
In total, 455 transcripts (35%) were up-regulated by DMI  and
471 (36%) were down-regulated by DMI. Finally, 148 transcripts
(11%) were induced by 3 M ATRA and 240 transcripts (18%) were
repressed by ATRA.
3.3. High-throughput miR expression proﬁling in ATRA-treated
and -untreated cells
Under the same culture conditions, miR  expression in ATRA-
treated and -untreated cells was analysed in two  independent
experiments. First, the quality of miR  expression data was  eval-
uated, including calculation of an average squared correlation
coefﬁcient r2 = 0.88 of the corresponding duplicates and using a
two-way analysis of variance (ANOVA) (critical p-value for signif-
icance: 0.01) to select signiﬁcantly regulated miRs. Furthermore,
only miRs exhibiting stable NanoString signal values (>50) at all
time points and with a twofold up- or down-regulation in at least
one time point were selected for further analysis. There were 23
miRs that fulﬁlled these criteria (Fig. 1d; the expression values are
presented in Tables 1 and 2. These 23 selected miRs were used for
the generation of the miR–mRNA network. As proof of the integrity
of our miR  expression assay data, the expression levels of three
putative adipogenesis-relevant miRs (miR-103, miR-146 and miR-
221) and ﬁve highly regulated miRs (miR-29a, miR29b, miR-365,
miR93 and miR96) were analysed by RT-qPCR (S1 and S2 Figures;
the corresponding expression values are summarised in the Sup-
porting information S3 and S4 Tables). The Pearson correlation
coefﬁcient between the nCounter miR  expression assay data and
the RT-qPCR was  highly signiﬁcant (r = 0.80) (S3a Figure). For the
calculation, we used the expression values of the above mentioned
miRs out of the miR  expression assays (Tables 1 and 2) as well as
the corresponding expression values of the RT-qPCR evaluation (see
the Supporting information S3 and S4 Tables).
3.4. Inhibition of fat cell differentiation by ATRA involves the
repression of adipogenic speciﬁc transcription factorsdifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
For microarray mRNA data validation, we  quantiﬁed the expres-
sion proﬁles of adipogenesis-speciﬁc transcription factors such as
Cebpˇ, Cebp˛, Ppar , Srebf1 and Rxr  ˛ (Fig. 2a–e). The expression
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Fig. 1. ATRA modulates the phenotype as well as the post-transcriptional mechanisms in 3T3-L1 cells. (A) Oil-red-O-staining of 3T3-L1 cells: Quantiﬁcation of lipid accumu-
lation  in DMI-treated (control) and DMI  + 3 M ATRA-treated 3T3-L1 cells. After the indicated times, DMI  (±3 M ATRA) was  replaced by growth medium without ATRA. Only
in  the labelled 96-h approach, DMI  + 3 M ATRA was changed to growth medium with ATRA for 288 h (12 d). (B) 3T3-L1 cell phenotypes: lipid accumulation in ATRA-treated
and  -untreated cells were visualised by microscopic images. (C) Relative gene expression trend, either up- or down-regulated, in the control and ATRA-treated cells in the
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oime  frame 2 h to 96 h (compared with 0 h). (D) MicroRNA expression proﬁling: Ex
he  expression changes in ATRA-treated 3T3-L1 cells are presented relative to the c
ccelerating red intensities, whereas decreasing ratios are represented by accelerat
hanges are presented relative to baseline. Compared with the
xpression proﬁle of Cebp  ˇ in DMI-treated cells ATRA has no inﬂu-
nce on Cebp  ˇ expression after 2 h (Fig. 2a). At 288 h (12 days)
ost-induction, Cebp  ˛ (FC = 86) (Fig. 2b), Ppar (FC = 37) (Fig. 2c),
rebf1 (FC = 7) (Fig. 2d) as well as Rxr  ˛ (FC = 10) (Fig. 2e) was  induced
y DMI  relative to 0 h, whereas the induction in ATRA-treated cells
as downregulated (Cebp˛; FC = 17, Ppar; FC = 9, Srebf1;  FC = 2,
xr˛; FC = 2). The microarray gene expression data were conﬁrmed
y RT-qPCR, and we also calculated the Pearson correlation coefﬁ-
ient between the microarray data and the RT-qPCR data (r = 0.7)
S3b Figure). For the calculation of the Pearson correlation coefﬁ-Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
ient, we used the expression values of the above mentioned genes
rom the microarray experiments as well as the expression values
f the RT-qPCR evaluation (S5–S8 Tables).on changes in ATRA-untreated 3T3-L1 cells are presented relative to 0 h, whereas
onding untreated samples. An increase in microRNA expression is represented by
een intensities.
3.5. Regulation of biological processes in ATRA-treated 3T3-L1
cells
We next examined the effects of treatment and exposure
time (0–96 h) to 3 M ATRA on biological processes in 3T3-L1
preadipocytes. An overview of the impact of DMI  as well as of ATRA
exposure on the regulation of biological processes is presented in
Fig. 3a. The effects of DMI  on biological processes during the early
stages (2, 4 and 7 h post-induction) and the mid stages (10 and 24 h
post-induction) were stronger than the regulatory effects of ATRA.
In the late stages (48 and 96 h post-induction) of early differen-differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
tiation, the regulation of GO terms by DMI and ATRA was almost
identical. In summary, at 2 h post-induction, 949 GO terms were
signiﬁcantly regulated by DMI  treatment, whereas only 112 GO
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Table  1
Changes in microRNA expression in DMI-treated 3T3-L1 cells.
microRNA 0 h DMI  2 h DMI  4 h DMI  7 h DMI  10 h DMI  24 h DMI  48 h DMI  96 h DMI  12d DMI
miR-99a 0 0,1 0,1 0,1 −0,1 −0,4 −0,3 1,1 1,5
miR-96 0 0 0,2 0 −0,1 −0,4 −0,7 −0,8 2,6
miR-93 0 0 0,1 0,2 0,3 0,9 0,6 0,2 0,2
miR-365 0 0,2 0,3 0,2 0,2 0,3 −0,1 0,6 2,3
miR-29b 0 −0,1 0,2 0,3 0,4 −0,3 −0,3 −1,1 −2
miR-29a 0 0 0,3 0,3 0,3 −0,1 −0,5 −1,1 −1,9
miR-27a 0 0,1 0,2 0,3 0 −0,2 0,2 0 −0,4
miR-23b 0 0 0,1 0 0,1 0,1 0,1 0,3 −0,4
miR-221 0 −0,1 −0,2 −0,3 −0,4 −0,9 −1,7 −1,7 −2,7
miR-218 0 0 −0,2 −0,3 0,1 −0,5 −0,1 −0,5 −1,5
miR-210 0 −0,3 −0,4 −0,4 0,1 0,3 0,6 −0,1 2,4
miR-21 0 0 0,1 0 0,1 −0,2 0 0 −1,6
miR-20a/20b 0 0 0,2 0,4 0,3 0,6 0,3 0,1 −1,1
miR-199a-5p 0 0,1 −0,1 −0,3 −0,2 −0,4 −0,1 −0,3 −1,3
miR-199a-3p 0 0,1 0,2 0,1 −0,1 −0,2 −0,2 −0,1 −1,2
miR-193 0 0 −0,2 0 0,1 −0,7 −0,5 0,6 2,3
miR-148a 0 0,1 0 −0,2 0 −0,6 −0,5 0,7 2,9
miR-146b 0 −0,1 0,1 0 0,4 0,2 0,4 0,8 1,3
miR-125b-5p 0 0,1 0,1 0 0 −0,2 −1 −1 −1,4
miR-125a-5p 0 0,2 0,1 0 −0,2 0 −0,4 −0,2 −0,6
miR-10b 0 −0,1 −0,2 −0,4 −0,3 −0,5 0 0,8 0,7
miR-103 0 0,2 0,2 0,2 0,3 0,4 0,8 1,8 3,2
miR-100 0 0,2 0 0,1 0 0 −0,7 −0,5 −0,2
Fold changes are presented relative to 0 h (log2-transformed ratios).
Table 2
Changes in microRNA expression in 3 M ATRA-treated 3T3-L1 cells.
microRNA 0 h ATRA 2 h ATRA 4 h ATRA 7 h ATRA 10 h ATRA 24 h ATRA 48 h ATRA 96 h ATRA 12d ATRA
miR-99a 0 0 0 −0,2 −0,1 0 0,1 −0,3 0,4
miR-96 0 0,2 −0,1 0,1 0,1 0,2 0,3 0,7 −2,8
miR-93 0 0 −0,1 −0,2 −0,2 −0,3 0,4 0,2 −0,8
miR-365 0 −0,1 0,1 0 0 −0,3 0,3 −0,7 −2,1
miR-29b 0 0,2 0 0,1 0,1 0,5 0,3 0,6 0
miR-29a 0 0 −0,1 0,1 0,2 0,2 0,5 0,6 0,7
miR-27a 0 0,1 −0,2 −0,2 0 −0,5 −0,9 −1 0
miR-23b 0 0 −0,1 0 0,2 0 0,3 0 0,4
miR-221 0 0,1 0,1 0,1 0,1 0,2 0,2 0,6 1,6
miR-218 0 0,1 0,2 0,3 0 0,3 −0,6 −0,4 0,7
miR-210 0 0,1 0,1 0 −0,1 0,3 0,4 −0,1 −2,9
miR-21 0 0 −0,1 0 0 0,2 −0,1 −0,1 0,5
miR-20a/20b 0 0 −0,1 −0,2 −0,2 −0,3 −0,2 −0,8 −0,5
miR-199a-5p 0 0 0,1 0,2 0,1 0 0,1 0,3 1,1
miR-199a-3p 0 0 0 0 0,3 0 −0,1 −0,1 1,1
miR-193 0 0,3 0,3 0 0,1 0,7 −0,4 −1,2 −2,3
miR-148a 0 0,2 0,1 0,2 0 0,3 0,2 −0,6 −2,4
miR-146b 0 0,2 −0,1 0 −0,3 −0,1 −0,2 −1,1 −2,1
miR-125b-5p 0 0 0 0 0,2 0 0,6 0,2 1
miR-125a-5p 0 −0,2 −0,1 0 0,2 −0,2 0,5 0,4 1
miR-10b 0 0,1 0,2 0,2 0 0 −0,7 −0,6 0,1
miR-103 0 0,2 0,1 0 0 0 0,2 −0,6 −1,6
F ransfo
t
m
d
o
t
A
w
(
a
p
a
smiR-100 0 0 0 −0,1 
old changes are presented relative to the corresponding untreated samples (log2-t
erms were regulated by ATRA treatment. The regulatory effects
ediated by ATRA gradually increased, and in the late stage of early
ifferentiation (48 and 96 h post-induction) the regulatory effects
f DMI  and ATRA were similar: 451 GO terms were subjected to
reatment with DMI  and even 471 GO terms were controlled by
TRA (Fig. 3a).
The most affected superclusters in early-stage differentiation
ere cell proliferation (blue rectangle) and tissue development
red rectangle) (S4a Figure). In mid-stage differentiation, the most
ffected superclusters were multicellular organism process (dark
urple rectangle), response to wounding (light purple rectangles)Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
nd cell proliferation (yellow rectangles) (S4b Figure). In the late
tages of differentiation (48/96 h post-induction), the most affected0,3 0,1 0,7 0,6 0,9
rmed ratio).
supercluster upon ATRA was found to be cellular lipid metabolism
(Fig. 3b).
3.6. The metabolism of 3T3-L1 cells is regulated by ATRA
In the next step, we analysed mRNA gene expression of key reg-
ulators within energy metabolism. The gene expression related to
triglyceride synthesis in 3T3-L1 cells was negatively inﬂuenced by
ATRA. In detail, the genes that were involved in beta-oxidation,
the tricarboxylic acid cycle (TCA cycle), fatty acid biosynthesis,
fatty acid transport, triglyceride synthesis, lipid accumulation asdifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
well as degradation of triacylglycerol for energy production were
down-regulated by ATRA (Table 3; Fig. 4). In this context, the
mRNA expression of acetyl-Co enzyme A dehydrogenase (Acadm),
acetyl-CoA acyltransferase 2 (Acaa2), phosphofructokinase (Pfkp),
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sig. 2. Quantitative analysis of mRNA expression by RT-qPCR of adipogenetic speci
 time course study (0–288 h). ATRA has no effect on the gene expression of (A) Ce
TRA.  Expression changes are presented relative to 0 h.
alate dehydrogenase 1 (Mdh1) and pyruvate carboxylase (Pcx)
as inhibited by ATRA in the late stage of differentiation. Isoci-
rate dehydrogenase 2 (Idh2) was down-regulated by ATRA after
4 h. The transcription of fatty acid synthase (Fasn) as well as fatty
cid-binding proteins 4 and 5 (Fabp4; Fabp5)  was  inhibited by
TRA. Triglyceride synthesis as well as lipid accumulation involves
he expression of 1-acylglycerol-3-phosphate O-acyltransferase 2
Agpat2), lipin 1 (Lpin1), diacylglycerol O-acyltransferase 2 (Dgat2)
nd perilipin (Plin) that were also inhibited by ATRA. In addition,
he gene expression pattern subjected to the degradation of tri-Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
cylglycerol was negatively regulated by ATRA; the expression of
ormone-sensitive lipase (Lipe) and lipoprotein lipase (Lpl) was  also
uppressed after 96 h.ulators in DMI-treated (red) and DMI  + 3 M ATRA-treated (blue) preadipocytes in
whereas the expression of (B) Cebp (C) Ppar (D) Srebf1 (E) Rxr is inhibited by
3.7. The regulation of biological pathways in ATRA-treated 3T3-L1
preadipocytes relative to the observed miR-mRNA interactions
Using a multiple linear regression model [49] combined with
the derived miR and mRNA expression data and the target predic-
tions of TargetScan Mouse 5.2 [44,50], an in silico based miR–mRNA
network was  generated (Fig. 5). Fig. 6 summarises the miR–mRNA
interactions with speciﬁc pathway annotations and the corre-
sponding expression proﬁles detected by our high-throughput
transcriptomic data screening (Tables 1–4). The comprehensivedifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
miR–mRNA networks are visualised in the Supporting informa-
tion S5–S7 Figures. Using our in silico based pathway-expression
analysis tools, we were able to show the following: 1) The most
affected pathways subjected to our data sets were gap junction sig-
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Fig. 3. Regulation of biological processes in DMI-treated and DMI  + 3 M ATRA-treated 3T3-L1 cells. (A) Regulated GO terms in DMI  and ATRA treated 3T3-L1 cells in early
stages  (2, 4 and 7 h post-induction) and mid  stages of differentiation (10 and 24 h), ATRA (blue) only has small effects on biological processes compared with DMI treatment
(red). (B) Cluster of ATRA regulated GO terms in the late stages of early differentiation (48/96 h post-induction). GO terms were analysed by the Genomatix Software and
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the  top 50 regulated GO terms per time were selected and visualised with Revigo. 
s  most affected by ATRA, shown in the left yellow supercluster. The size of the rec
nrichments are given at the bottom.
alling (functional locality score = 2.86E-06), the rearrangement of
he actin cytoskeleton (functional locality score = 1.06E-10) and the
egulation of the TCA cycle (functional locality score = 5.84E-26). 2)
iR-27a and miR-96 are probably the most important co-actors in
hese pathways, in which miR-27a is inhibited by ATRA and miR-
6 is induced by ATRA. 3) Using in silico-based tools, we were also
ble to visualise the interactions of miRs with mRNAs with spe-
iﬁc pathway annotation (mRNAs are visualised as rectangles in
he Supporting information S5–S7 Figures) subjected to our own
xpression data sets. Therefore, in silico, we could visualise the pre-Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
icted interactions of miR-27a and the corresponding transcripts
uch as the platelet-derived growth factor receptor, alpha polypep-
ide (Pdgfra), son of sevenless 1 (Sos1), vav 3 oncogene (Vav3) andte regulation (48 and 96 h) of GO terms is visualised. The cellular lipid metabolism
es represents the level of signiﬁcance, whereby the log10 p-values of the GO term
LIM kinase 2 (Limk2). All mentioned genes are associated with
gap junction signalling on the basis of the information of KEGG
pathways (KEGG: mmu04540) (Fig. 6a) as well as the rearrange-
ment of the cytoskeleton (Fig. 6b) (KEGG-Pathway: mmu04810).
Furthermore, we visualised the interaction of miR-96 with the pre-
dicted transcripts of the WAS  protein family, member 2 (Wasf2),
the actin related protein 2/3 complex (Arp2/3) [51] and the mus-
cle and microspike RAS (Mras). All these mentioned genes are
also directly involved in cytoskeleton regulation (KEGG-Pathway:
mmu04810). In addition to the potential regulatory effects of miR-differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
96 inside the actin cytoskeleton (Fig. 6b), Pcx and dihydrolipoamide
S-acetyltransferase, the E2 component of the pyruvate dehydro-
genase complex (Dlat), which are key regulators of the TCA cycle
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Table  3
Changes in mRNA expression in ATRA-treated 3T3-L1 cells.
Gene name Gene description 2h 4h 7h 10h 24h 48h 96h
Acadm acyl-Coenzyme A dehydrogenase, medium chain 0,1 0,3 −0,1 0,1 −0,3 −1,1 −1,4
Acaa2  acetyl-Coenzyme A acyltransferase 2 0,2 0,6 1 0,9 0,7 0,3 −0,3
Pfkfb4  6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 0,5 1 1,2 0,9 1,2 0,7 0,8
Pfkp  phosphofructokinase, platelet 0 −0,1 −0,2 −0,3 −0,1 −1,4 −1,8
Gpi1  glucose phosphate isomerase 1 0,4 0,7 0,7 0,5 0,9 1 0,8
Mdh1  malate dehydrogenase 1, NAD (soluble) −0,1 0,2 0 0,1 0,1 −0,4 −1,2
Pcx  pyruvate carboxylase 0,1 0,2 0 0,8 1 0 −0,5
Dlat  dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) 0 0 0 0,1 0,1 −0,3 −0,9
Pdk4  pyruvate dehydrogenase kinase, isoenzyme 4 1 1,1 0,2 1,4 0,6 0,6 −0,2
Aco1  aconitase 1 0,1 0,1 0,1 0 −0,1 −0,3 −1,2
Idh3a  isocitrate dehydrogenase 3 (NAD+) alpha 0,1 0,2 0,1 0 0,7 0,1 −1,3
Idh2  isocitrate dehydrogenase 2 (NADP+), mitochondrial 0 0 −0,4 −0,1 −0,6 −1,2 −0,6
Fasn  fatty acid synthase 0,1 −0,1 0 0 0,1 −0,3 −1,3
Scd1  stearoyl-Coenzyme A desaturase 1 1,2 1,3 1 0,5 1,5 0,2 −0,8
Acsl1  acyl-CoA synthetase long-chain family member 1 0 −0,4 −0,2 −0,4 −0,4 −2,5 −3,3
Acsl4  acyl-CoA synthetase long-chain family member 4 0,4 0 0,4 0 0,6 1,1 1,6
Fabp4  fatty acid binding protein 4, adipocyte −0,1 0 0,5 0,3 0,8 −0,6 −1,3
Fabp5  fatty acid binding protein 5, epidermal −0,3 0 0,2 0,4 0,5 −0,5 −1,3
Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 0,1 −0,4 −0,4 −0,3 −0,7 −1,7 −2,9
Lpin1  lipin 1 0 0,3 −0,2 0 −0,1 −1,3 −1,8
Dgat1  diacylglycerol O-acyltransferase 1 0,5 0,9 0,4 0,1 −0,1 −1,7 −2,4
Dgat2  diacylglycerol O-acyltransferase 2 0 0,1 0,1 0 −0,2 −1,6 −2,5
Plin  perilipin −0,1 0 0,1 0 0,1 0,1 −1,4
Lipe  lipase, hormone sensitive 0,1 0,2 −0,3 0 −0,2 −1,5 −2,6
Lpl  lipoprotein lipase 0 −0,1 0,1 0,5 1,1 0,7 −0,2
Pnpla2 patatin-like phospholipase domain containing 2 0,1 0 −0,1 0,1 −0,5 −2,7 −2,5
Pdgfra platelet derived growth factor receptor, alpha polypeptide 0,3 1,3 1 1,5 1,5 2 2,1
Adcy6  adenylate cyclase 6 0,2 0,3 0 0,3 0,6 0,7 0,9
Sos1  Son of sevenless homolog 1 (Drosophila) 0,1 0 0,2 0,1 0,1 0,4 0,3
Mras  muscle and microspikes RAS 0 −0,1 −0,2 0,1 −0,1 −0,9 −0,7
Vav3  vav 3 oncogene 0,1 −0,1 0,1 0,3 0,1 0,2 0,7
Pak3  p21 (CDKN1A)-activated kinase 3 0 −0,3 −0,2 0,2 0,1 0,2 1
Wasf2  WAS  protein family, member 2 0 −0,2 −0,4 0,1 −0,1 −0,4 −0,2
Limk2  LIM motif-containing protein kinase 2 0,2 0,4 0,2 0,1 0,4 1,1 0,7
Arp2/3  Actin related protein 2/3 0 0 −0,2 −0,1 −0,2 −0,1 −0,5
Fold changes are presented relative to the corresponding untreated samples (log2-transformed ratios).
Table 4
Changes in mRNA expression in DMI-treated 3T3-L1 cells.
Gene name Gene description 2h 4h 7h 10h 24h 48h 96h
Pcx pyruvate carboxylase −0,1 −0,2 −0,4 −0,4 0,8 2,6 3,2
Dlat  dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) 0 0 0 −0,1 0,4 0,7 1,5
Pdgfra  platelet derived growth factor receptor, alpha polypeptide −1,5 −2,8 −2,7 −2,1 −2,1 −2,4 −2,8
Adcy6  adenylate cyclase 6 −0,6 −0,7 −0,5 −0,7 −0,6 0 −0,1
Sos1  Son of sevenless homolog 1 (Drosophila) −0,4 −0,4 −0,1 0 0 −0,1 0,2
Mras  muscle and microspikes RAS 0 −0,5 −0,6 −0,4 −0,2 0,7 0,5
Vav3  vav 3 oncogene 0 −0,1 −0,2 −0,1 −0,1 0,1 0
Pak3  p21 (CDKN1A)-activated kinase 3 0,3 −0,2 −0,7 −0,9 −0,5 −0,3 −0,9
Wasf2  WAS  protein family, member 2 −0,2 −0,7 −0,8 −0,8 −0,3 0,1 0
Limk2  LIM motif-containing protein kinase 2 −0,1 0,1 0,1 0 0,1 0,7 1,4
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KEGG-Pathway: mmu00020) [52] are forecasted as targets of miR-
6 by TargetScan Mouse (Fig. 6c).
. Discussion
There is increasing evidence that miRs play a very important role
n metabolism and energy homeostasis. Therefore, this regulatory
mall RNA species may  be involved in the pathogenesis of disorders
uch as the metabolic syndrome or type 2 diabetes. In this study,
e used large-scale transcriptomic methods to proﬁle the global
xpression of miRs and mRNAs in 3T3-L1 preadipocytes in a high-
esolution time frame. We  combined these data to generate globalPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
olecular networks in order to explain the phenotype of ATRA-
reated 3T3-L1 cells (Fig. 1b).
It is known from the literature [5,10,11] that 3T3-L1 cells are
ery sensitive to ATRA exposure during the early stages of differen-−0,1 0,1 0,3 0,5 0,8 0,5 1
tiation; however, simultaneously, the ATRA-dependent inhibition
is reversible within the ﬁrst 48 h [11]. This may  imply that
the longer the incubation time with ATRA, the stronger are the
inhibitory effects of ATRA on fat cell differentiation. We  could
conﬁrm this effect on phenotypic development (Fig. 1a and b).
Moreover, these results are in accordance with our transcriptomic
data (Figs. 1c and Fig. 2).
In our experiments, a modulation of miR expression in DMI
as well as in ATRA-treated cells was observed after 24 h but not
at earlier stages of differentiation, suggesting that miRs modulate
adipocyte differentiation after induction of this program (Fig. 1d).
Similar time-dependent miR  expression patterns for DMI-induceddifferentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
differentiation of 3T3-L1 cells have been reported by Kajimoto et al.
[53] for the TPA-induced differentiation of HL-60 cells [54] as well
as for the neuronal differentiation of primary rat cortical cells [55].
Moreover, our miR  expression data (Fig. 1d) conﬁrm the ﬁndings of
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eig. 4. Schematic overview of metabolic processes that are affected by ATRA during
ene expression changes in ATRA-treated 3T3-L1 cells are presented relative to th
reater  than 1.5.
ie (2009) [56] and Knelangen [57] that miR-221 and miR-125b-5pPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
Integrative analysis of transcriptomic and phenotypic data, Biomol De
re down-regulated during differentiation of 3T3-L1 cells, whereas
iR-103 and miR-146b are up-regulated. To our knowledge, our
tudy is the ﬁrst detailed report on the complex modulation of miR
xpression in 3T3-L1 preadipocytes by ATRA.genesis in 3T3-L1 cells over 96 h. The highlighted genes are direct targets of Ppar .
esponding untreated samples. The colour code reﬂects an up- or down-regulation
Similar to the mRNA and miR  expression pattern, no adipocyte-differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
speciﬁc GO terms were enriched in ATRA-treated cells during the
early and mid  stages of differentiation (see the Supporting infor-
mation S4a and S4b Figs.). A possible explanation for this ﬁnding is
that on one hand, it was shown that the mitotic clonal expansion is
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fig. 5. Joint analysis of real microRNA and mRNA data on the basis of target predi
etwork correspond to an association of the microRNA to the gene sequence and its
f  the respective microRNA-mRNA relation in the multiple regression model).
ot affected by ATRA [16,58], while on the other hand, it is known
nd conﬁrmed by our data that the inhibitory effects of ATRA are
eversible during the ﬁrst 48 h of differentiation (Fig. 1a and b) [11].
In Fig. 4, the mRNA-based regulation of metabolism in ATRA-
reated cells is summarised. We  could show that in the presence
f ATRA, transcripts encoding for important metabolic enzymes
nd kinases related to energy production are down-regulated. For
xample, genes involved in fatty acid biosynthesis were suppressed
y ATRA exposure. The gene activity of Fasn [59], an enzyme that
atalyses the synthesis of long chain fatty acids, was  inhibited. Per-
lipin (Plin) is a protein that is located at the surface of lipid droplets
nd controls both lipid storage and activation of lipolysis [60–62].
n ATRA-treated cells, no lipids were accumulated for storage orPlease cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
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ipolysis (Fig. 1b), and one possible explanation is that the mRNA
xpression of Plin was down-regulated by ATRA after 96 h; there-
ore, the protein production of Plin is possibly inhibited.of TargetScan Mouse 5.2 [44] and a linear regression model [49]. The edges in the
ssion level. The edge weights denote the anti-correlation (=the negative coefﬁcient
The TCA cycle is a central metabolic pathway [63] that combines
the anabolism as well as catabolism of biomolecules such as amino
acids, monosaccharides and fatty acids [64,65]. Rate-limiting steps
in metabolism are normally key positions for regulation, such as
starting points for other pathways. Newton et al. [2011] showed
that developing preadipocytes enter a state of metabolic-overdrive,
where the activity of the TCA cycle is increased [66]. Our results
indicate that ATRA can mitigate this exaggerated induction at the
level of transcription. For example, the expression of Pdha1, which
catalyses with Pcx the pyruvate entry as acetyl-CoA in the TCA,
can be inhibited by pyruvate dehydrogenase kinase, isoenzyme 4
(Pdk4), which is located in the mitochondrial matrix [67]. Attia et al.
showed that the transcript of Pdk4 is up-regulated by ATRA [68].differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
We could also demonstrate that the gene expression of Pdk4 was
induced after 2, 4, 10, 24 and 48 h by ATRA.
Post-transcriptional regulation of transcription by miRs is a very
important process for metabolic processes and thereby for later
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Fig. 6. Overview of the most signiﬁcantly regulated KEGG pathways in ATRA-treated 3T3-L1 cells after in silico-based joint analysis of microRNA and mRNA data with
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ohe  corresponding expression data over time and treatment. Expression changes 
amples. The colour code reﬂects a regulation greater than 1.5. (A) Gap junction, (B
upplementary S5–S7 Figures).
henotype formation. Hence, analysis of the mRNA–miR interplay
ollowed by signal transduction is a crucial aspect with regard
o the regulation of metabolic pathways. For the communication
etween adjoined cells, gap junctions are required. Communica-
ion by gap junctions is very sensitive to a multitude of stimuli
2+Please cite this article in press as: K. Stoecker, et al., Inhibition of fat cell 
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ncluding changes in the concentration of intracellular Ca , cAMP,
P3 and phosphorylation/dephosphorylation processes mediated
y kinases [69]. In Fig. 6a, the miR–mRNA-dependent regulation
f gap junction signalling is shown. From the target predictions ATRA-treated 3T3-L1 cells are presented relative to the corresponding untreated
lation of actin cytoskeleton, (C) TCA cycle. (For the whole network, see electronic
of TargetScan Mouse and our in silico based analysis, we know
that miR-27a exhibits binding sites for Pdgfra,  a receptor tyro-
sine kinase that is a known suppressor of adipogenesis and Ppar
activity [70,71]. Pdgfra is enriched in non-adipogenic cells and
is able to mediate anti-adipogenic activities in 3T3-L1 cells [70].differentiation in 3T3-L1 pre-adipocytes by all-trans retinoic acid:
tect Quantif (2016), http://dx.doi.org/10.1016/j.bdq.2016.11.001
Therefore, anti-adipogenic functions could be mediated in 3T3-L1
cells if Pdgfra is activated. During fat cell differentiation, the gene
expression of Pdgfra is down-regulated; therefore, the inhibition
of connexin communication between cells may  occur. Hence, the
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dgfra-mediated anti-adipogenic signal cascade is inhibited during
dipogenesis [72]. Down-regulation of miR-27a by ATRA may  cause
he induction of Pdgfra and the activation of the anti-adipogenetic
ignal cascade.
The rearrangement of the cytoskeleton is essential for cell shape,
ell mobility as well as intracellular transport [73]. This rear-
angement depends on a highly sophisticated signalling cascade,
ncluding actin depolymerisation and rearrangement as well as
ctin ﬁlament reorganisation. We  showed that miR-96 is a miR  that
s associated with the rearrangement of the cytoskeleton (Fig. 6b)
hrough targeting genes with pathway-speciﬁc annotations (rect-
ngle labelled genes in the Supporting information S6 Fig.). Laine
t al. have already shown the importance of miR-96 for differ-
nt developing processes in human mesenchymal stromal cells
74]. Interestingly, on day 12 (288 h), the regulation of miR-96 was
nverse compared with the expression proﬁle at earlier time points;
MI  induced and ATRA repressed the expression of miR-96 (Figs.
d and 6b). Recently, Xie et al. showed that miRs that are induced
uring adipogenesis tend to be down-regulated in the obese state
nd vice versa [56]. Our explanation for the inverse expression of
iR-96 is that in DMI-treated cells, miR-96 is repressed during dif-
erentiation and the pro-adipogenic signalling cascade is switched
n. After 288 h (12 days), lipid ﬁlling is completed and transcrip-
ion factors for terminal differentiation have to be switched off.
or this purpose, an induction of miR-96 is required. MiR-96 is
nduced by ATRA after 96 h; therefore, pro-adipogenic factors are
nhibited and lipogenesis is suppressed. In addition, Arp2/3 and
asf2 build the WAVE complex [75], which also takes part in
ctin ﬁlament reorganisation, because the gene product of Wasf2
an mediate the association of receptor kinases and actin [76–78].
nterestingly, Arp2/3 is forecasted as a further target of miR-96 by
argetScan Mouse. Therefore, the miR-96–Arp2/3 interaction may
e a central step in the regulation of the rearrangement of the actin
ytoskeleton in 3T3-L1 preadipocytes and in the conversion of 3T3-
1 cells from a ﬁbroblast-like to mature adipocyte-like morphology.
o conﬁrm our hypothesis, further studies, including knockdown
xperiments as well as overexpression experiments, are necessary.
. Conclusion
In summary, in this comprehensive study of high-throughput
ata, we generated a global miR–mRNA interaction network to
xplain physiological and morphological changes modulated by
TRA in 3T3-L1 pre-adipocytes. We  could show that the cellular
ipid metabolism is negatively affected by ATRA. Furthermore, we
ere able to demonstrate that miR-27a and/or miR-96 are very
mportant regulators and gap junction signalling, the rearrange-
ent of the actin cytoskeleton as well as the citric acid cycle are the
ost affected pathways with regard to inhibitory effects of ATRA in
T3-L1 preadipocytes. The experimental workﬂow and the integra-
ive microRNA–mRNA data analysis shown in this study represents
 possibility for illustrating interactions in highly orchestrated bio-
ogical processes. On the other hand, this model of data analysis
ay  also be used for the pre-selection of potential new biomarkers
ith regard to obesity or for the identiﬁcation of new pharmaceu-
ical targets.
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